Can Jim Cramer Reignite Medical & Healthcare Stocks? (DNA, SNN, BDX, BAX)
This week’s features from Jim Cramer on CNBC’s MAD MONEY are right up the alley of BioHealthInvestor.com. Whether or not they are right up investor-alley is another issue. Cramer is revisiting some names he thinks you can hide out in for safety.
On Monday, Cramer came out calling Genentech (NYSE: DNA) his pick in biotechs. He noted that it could head to $88 per share if his 1990′s scenario pans out.
On Tuesday, Cramer anointed Smith & Nephew (NYSE: SNN) as he called the stock his favorite in the health care sector. He believes much of the past issues are behind it and you can get in now.
On Wednesday night, Cramer came out with an interesting call in Becton Dickinson (NYSE: BDX). As it is the staples company for hospitals and medical offices, he thinks they are safe during hard times with it that far off of 52-week highs.
One call he changed was his reversal or exit on Baxter International Inc. (NYSE: BAX). He had been bullish on this one and with it up this high he said it’s time to ring the register.
Stay tuned, because he’s got Thursday night and Friday night picks in various parts of healthcare, medical, biotech, pharma, and more.
Jon Ogg
July 10, 2008
